China Digital Healthtech Taimei Technology Receives Approval for Hong Kong IPO, Raised $413 Million with Investors Including Tencent, Yunfeng Capital, SoftBank Group & Hillhouse Capital, Taimei Technology was Founded in 2013 by CEO Lu Zhao, Lu Zhao & Wife with 33.3% Shareholdings
20th September 2024 | Hong Kong
China digital healthtech Taimei Technology has received approval for a Hong Kong IPO. Taimei Technology has raised more than $413 million with investors including Tencent, Yunfeng Capital, SoftBank Group & Hillhouse Capital. Taimei Technology was founded in 2013 by CEO Lu Zhao. Lu Zhao & his wife own 33.3% shareholdings of Taimei Technology. Taimei Technology – Taimei Technology is a pioneering healthtech company focused on building a digital ecosystem for the life science industry. Dedicated to leveraging digital solutions to revolutionize and accelerate clinical research, our digital platform for the life sciences includes Clinical Data Management, Clinical Operations and Pharmacovigilance solutions to connect key stakeholders involved in clinical research. Driven by a genuine passion for patients’ well-being, our commitment lies in empowering pharmaceutical companies, CROs, and sites with innovative solutions to ensure accelerated drug research and development, quicker medicine launches, and enhanced business performance. Founded more than 10 years ago, Taimei Technology has been offering clinical technology solutions for thousands of sponsors and hundreds of clinical service providers and has empowered over 7,000 clinical trials. Our global market coverage in North America, Asia Pacific, and Europe and database integration capabilities with regulatory agencies in more than 30 countries are a testament to our commitment to providing comprehensive solutions to our clients. At its core, Taimei Technology values technological innovation to tackle critical challenges in the pharmaceutical R&D industry, ensuring a holistic approach that benefits not just their clients but improves the lives of patients around the world.
“ China Digital Healthtech Taimei Technology Receives Approval for Hong Kong IPO, Raised $413 Million with Investors Including Tencent, Yunfeng Capital, SoftBank Group & Hillhouse Capital, Taimei Technology was Founded in 2013 by CEO Lu Zhao, Lu Zhao & Wife with 33.3% Shareholdings “
China Digital Healthtech Taimei Technology Receives Approval for Hong Kong IPO, Raised $413 Million with Investors Including Tencent, Yunfeng Capital, SoftBank Group & Hillhouse Capital, Taimei Technology was Founded in 2013 by CEO Lu Zhao, Lu Zhao & Wife with 33.3% Shareholdings
Sign Up / Register
Caproasia Users
- Manage $20 million to $3 billion of assets
- Invest $3 million to $300 million
- Advise institutions, billionaires, UHNWs & HNWs
Caproasia Platforms | 11,000 Investors & Advisors
- Caproasia.com
- Caproasia Access
- Caproasia Events
- The Financial Centre | Find Services
- Membership
- Family Office Circle
- Professional Investor Circle
- Investor Relations Network
Monthly Roundtable & Networking
Family Office Programs
The 2024 Investment Day
- March 2024 - Hong Kong
- March 2024 - Singapore
- July 2024 - Hong Kong
- July 2024 - Singapore
- Sept 2024 - Hong Kong
- Sept 2024 - Singapore
- Oct 2024 - Hong Kong
- Nov 2024 - Singapore
- Visit: The Investment Day | Register: Click here
Caproasia Summits
- The Institutional Investor Summit
- The Investment / Alternatives Summit
- The Private Wealth Summit
- The Family Office Summit
- The CEO & Entrepreneur Summit
- The Capital Markets Summit
- The ESG / Sustainable Investment Summit
